Donald M. Lloyd-Jones, MD
Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Preventive Medicine & Epidemiology




Dr. Lloyd-Jones’ research interests include the study of the mechanisms and life course of cardiovascular health and healthy aging, and cardiovascular disease epidemiology, risk estimation and prevention. Other areas of interest include the use of novel biomarkers and imaging of subclinical atherosclerosis to improve prevention, and the epidemiology and outcomes of hypertension and dyslipidemia. His clinical and teaching interests lie in general cardiology, with a focus on prevention.

He also has been a national leader in public health and clinical approaches to promoting cardiovascular health and preventing cardiovascular diseases across the life course. He served as co-chair of the Risk Assessment Guidelines and a member of the Cholesterol Treatment Guidelines Panel for the 2013 ACC/AHA Guidelines for Cardiovascular Disease Risk Reduction; and was the lead member for risk assessment on the 2018 Cholesterol Guidelines Panel and the 2019 Primary Prevention Guidelines Panel. He has authored over 750 peer-reviewed scientific publications and has been a PI or co-investigator on more than 120 grants (the vast majority from NIH)

Director of Framingham Center for Population and Prevention Science
Boston University
Framingham Heart Study


Principal Investigator of the Framingham Heart Study
Boston University
Framingham Heart Study


Chief of the section of Preventive Medicine
Boston University
Preventive Medicine




Genetic Architecture of Cardiac Structure and Function and Its Impact on Heart Failure
01/01/2025 - 06/30/2026 (Subcontract PI)
University of Texas Health Science Center, Houston NIH NHLBI
5R01HL160793-03



Title


Yr Title Project-Sub Proj Pubs
2025 Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH) 5R01HL160921-03
2024 Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH) 5R01HL160921-02
2023 Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH) 1R01HL160921-01A1
2023 The Fragile Families Cardiovascular Health Follow Up Study 5R01HL149869-04
2022 The Fragile Families Cardiovascular Health Follow Up Study 5R01HL149869-03
2021 The Fragile Families Cardiovascular Health Follow Up Study 5R01HL149869-02
2020 The Fragile Families Cardiovascular Health Follow Up Study 1R01HL149869-01A1
2019 Northwestern University Clinical and Translational Science Institute (NUCATS) 2UL1TR001422-05A1 667
2018 Northwestern University Clinical and Translational Science Institute (NUCATS) 3UL1TR001422-04S2 667
2018 Northwestern University Clinical and Translational Science Institute (NUCATS) 3UL1TR001422-04S1 667
Showing 10 of 32 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Bhatt SP, Wu C, Sun Y, Balte PP, Schwartz JE, Divo MJ, Jaeger BC, Chaves PH, Couper D, Jacobs DR, Lloyd-Jones D, Kalhan R, Newman AB, O'Connor GT, Umans JG, White WB, Yende S, Oelsner EC. Low Lung Function Is Associated with High Population Attributable Fraction for Cardiovascular Mortality. Ann Am Thorac Soc. 2025 Mar; 22(3):359-366.View Related Profiles. PMID: 39447115
     
  2. Szeto MD, Ning H, Pedamallu H, Zheng Y, Schneper L, Joyce B, Kim K, Kershaw KN, Reges O, Hou L, Allen NB, Notterman DA, Lloyd-Jones DM. Mediation of Social Determinants and Hypertension by Epigenetic Age in CARDIA. Hypertension. 2025 Mar; 82(3):e22-e24. PMID: 39970248; PMCID: PMC11841923; DOI: 10.1161/HYPERTENSIONAHA.124.24080;
     
  3. Iyer KR, Clarke SL, Guarischi-Sousa R, Gjoni K, Heath AS, Young EP, Stitziel NO, Laurie C, Broome JG, Khan AT, Lewis JP, Xu H, Montasser ME, Ashley KE, Hasbani NR, Boerwinkle E, Morrison AC, Chami N, Do R, Rocheleau G, Lloyd-Jones DM, Lemaitre RN, Bis JC, Floyd JS, Kinney GL, Bowden DW, Palmer ND, Benjamin EJ, Nayor M, Yanek LR, Kral BG, Becker LC, Kardia SLR, Smith JA, Bielak LF, Norwood AF, Min YI, Carson AP, Post WS, Rich SS, Herrington D, Guo X, Taylor KD, Manson JE, Franceschini N, Pollard KS, Mitchell BD, Loos RJF, Fornage M, Hou L, Psaty BM, Young KA, Regan EA, Freedman BI, Vasan RS, Levy D, Mathias RA, Peyser PA, Raffield LM, Kooperberg C, Reiner AP, Rotter JI, Jun G, de Vries PS, Assimes TL. Unveiling the Genetic Landscape of Coronary Artery Disease Through Common and Rare Structural Variants. J Am Heart Assoc. 2025 Feb 18; 14(4):e036499.View Related Profiles. PMID: 39950338
     
  4. Lloyd-Jones DM, Khan S. Statins for Primary Prevention of Cardiovascular Disease-Reply. JAMA. 2025 Feb 12. PMID: 39937489; DOI: 10.1001/jama.2024.26594;
     
  5. Wolska A, Lloyd-Jones DM, Remaley AT. Measure Apolipoprotein B If We Believe What We Say About Precision Medicine. Circulation. 2025 Feb 04; 151(5):257-259. PMID: 39899636; PMCID: PMC11801237; DOI: 10.1161/CIRCULATIONAHA.123.067559;
     
  6. Zhao D, Yao J, Li Y, Jacobs DR, Zheng Y, Liu C, Fu Y, Deangelis MM, Lloyd-Jones D, Hou L, Zhang K. Associations of long-term exposure to temperature with coronary artery calcification risk among middle-aged adults: The Coronary Artery Risk Development in Young Adults (CARDIA) study. Sci Total Environ. 2025 Feb 25; 966:178675. PMID: 39904207; DOI: 10.1016/j.scitotenv.2025.178675;
     
  7. Cameron NA, Huang X, Petito LC, Ning H, Shah NS, Yee LM, Perak AM, Haas DM, Mercer BM, Parry S, Saade GR, Silver RM, Simhan HN, Reddy UM, Varagic J, Licon E, Greenland P, Lloyd-Jones DM, Kershaw KN, Grobman WA, Khan SS. Determinants of Racial and Ethnic Differences in Maternal Cardiovascular Health in Early Pregnancy. Circ Cardiovasc Qual Outcomes. 2025 Jan 14; e011217. PMID: 39807595
     
  8. McDermott MM, Sufit R, Domanchuk KJ, Volpe NJ, Kosmac K, Peterson CA, Zhao L, Tian L, Zhang D, Xu S, Ismaeel A, Ferrucci L, Parekh ND, Lloyd-Jones D, Kramer CM, Leeuwenburgh C, Ho K, Criqui MH, Polonsky T, Guralnik JM, Kibbe MR. Hepatocyte growth factor for walking performance in peripheral artery disease. J Vasc Surg. 2025 Jan 06. PMID: 39778757
     
  9. Guo JW, Ning H, Lloyd-Jones DM. Cardiovascular Health Status in US Adults With Chronic Diseases: National Health and Nutrition Examination Survey (NHANES), 2013-2018. J Am Heart Assoc. 2025 Jan 07; 14(1):e034388. PMID: 39719405
     
  10. Sattler ELP, Lassale C, Diaw M, Joseph JJ, Singh G, Samb A, Lloyd-Jones DM, Gaye B. Changes in Cardiovascular Health at Midlife and Subsequent Cardiovascular Outcomes in Individuals With Diabetes. JACC Adv. 2025 Jan; 4(1):101450. PMID: 39801817; PMCID: PMC11719311; DOI: 10.1016/j.jacadv.2024.101450;
     
Showing 10 of 701 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 701 publications over 24 distinct years, with a maximum of 77 publications in 2021

YearPublications
20025
20034
200410
200515
200612
200713
200811
200919
201012
201127
201228
201327
201422
201539
201632
201738
201834
201943
202064
202177
202276
202346
202439
20258

Contact for Mentoring:

72 E. Concord St
Boston MA 02118
Google Map


Lloyd-Jones's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department